Developer docs
API playgroundTry for free, no card

Search company profiles

WallachBeth Capital

Full company profile

uuid0004boi

Namestring
WallachBeth Capital
Legal namestring
WallachBeth Capital, LLC
Websiteurl
wallachbeth.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

WallachBeth Capital is a privately held, FINRA-registered broker-dealer founded in 2014 and headquartered in Jersey City, NJ with an additional office in Boca Raton, FL. The firm operates on a fully disclosed, agency-only basis across three integrated service lines: Execution Services (custom execution in equities, ETFs, and derivatives, including risk-market liquidity sourcing, creation/redemption baskets, high-touch program trading, NAV markets, and algorithmic venues, plus outsourced trading for asset managers); Consulting Services (risk management, portfolio solutions, execution consulting, and bespoke market intelligence); and Capital Markets (IPOs, registered direct offerings, PIPEs, private placements, bridge financing, and financial advisory, with a stated track record of over $1.5 billion in equity and debt capital raised for clients). The firm does not own an ATS or operate a principal market-making desk, which is the structural source of its "no conflicts" positioning.

The platform's underlying technology stack comprises an internal proprietary electronic trading platform (Phase I rolled out in 2020) and a comprehensive algorithm suite leveraging partner-provided technology, with no disclosed in-house AI/ML capabilities. Revenue is generated via transaction-based execution fees, capital markets placement and underwriting fees, and professional-services consulting fees, with pricing not publicly disclosed and negotiated on a relationship basis. Distribution is direct via sales-led, enterprise-style relationship management rather than through reseller or platform channels.

WallachBeth serves two primary customer segments: (1) institutional investors — asset managers, hedge funds, and financial institutions — that require agency execution, derivatives facilitation, and outsourced trading; and (2) small-to-mid-cap innovative companies in biotech, pharmaceutical, medtech, diagnostic, and telehealth that need capital markets and investment banking expertise. A separate Financial Services and FinTech vertical was established in 2018 under Managing Director Dave Mortimer. The firm also maintains ecosystem marketing through its annual Park City Symposium, financial media appearances on CNBC and Bloomberg, and industry event sponsorships.

Short descriptiontext

WallachBeth Capital is a privately held, FINRA-registered broker-dealer that provides agency-only institutional execution, consulting, and capital markets services to asset managers, hedge funds, and small-to-mid-cap healthcare/biotech issuers, with over $1.5 billion raised for clients since 2014.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
institutional execution services, agency-only brokerage, capital markets advisory, ETF and equity trading, healthcare investment banking
Industry3 codes
1Agency Equity Execution (Cash Equities)
CodeFSACAFAAPrimaryYes
2Capital Raising Advisory (Equity & Equity-Linked)
CodeFSAEAGACPrimaryNo
3Prime Brokerage Financing (Margin/Stock Loan)
CodeFSACAIADPrimaryNo
NAICS code3 codes
  • Investment Banking and Securities Intermediation523150
  • Investment Banking and Securities Intermediation52315
  • Portfolio Management and Investment Advice52394
SIC code2 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Investment Advice6282
Product category
Institutional Brokerage & Capital Markets
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Capital Markets and Investment Banking Services
TypeProfessional Services
Description

Fees earned from capital raising activities including IPOs, registered direct offerings, follow-on offerings, PIPE offerings, private placements, uplisting transactions, bridge financing, and financial advisory for small to medium-sized healthcare and biotech companies. WallachBeth has helped companies raise over $1.5 billion in equity and debt capital.

wallachbeth.com
2Institutional Execution Services
TypeTransaction Fee
Description

Agency-based execution services for equities, ETFs, and derivatives. Operating on fully disclosed, agency-only basis providing execution strategies, consulting, and outsourced trading capabilities to institutional clients.

wallachbeth.com
3Consulting Services
TypeProfessional Services
Description

Consultative services including risk management, portfolio solutions, execution consulting, and intelligence. Services are asset and security-type agnostic.

wallachbeth.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

WallachBeth Capital is a boutique institutional broker-dealer providing execution, consulting, and capital markets services on a fully disclosed, agency-only basis. Its Execution practice delivers equities, ETF, and derivatives execution with algorithmic and outsourced trading capabilities for asset managers and hedge funds. Its Capital Markets practice provides investment banking services — IPOs, registered direct offerings, PIPE offerings, private placements, uplistings, bridge financing, and financial advisory — focused on small-to-mid-cap healthcare and biotech issuers, with over $1.5 billion in client capital raised.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over $1.5 billion in equity and debt capital raised for client companies
Product overview1 text field

WallachBeth Capital is a leading provider of institutional execution services offering a unified platform of Execution, Consulting, and Capital Markets services. The Execution Services core product includes Equities & ETFs, Derivatives, Electronic Trading, and Outsourced Trading sub-products that help institutions navigate complex markets on an agency-only basis. The Consulting Services encompass Risk Management, Portfolio Solutions, Execution Consulting, and Intelligence offerings. The Capital Markets division provides investment banking services including IPOs, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, having helped companies raise over $1.5 billion in Equity and Debt Capital, with a specialty focus on small to medium-sized innovative Biotech/Pharmaceutical/Medtech/Diagnostic/Telehealth companies.

Product and service3 records
1Execution Services
CategoryInstitutional Execution / Agency Brokerage
Description

Institutional execution solutions spanning equities, ETFs, and derivatives, including Equities & ETFs (risk markets, creation/redemption baskets, high-touch program trading, NAV markets, algorithmic venues), Derivatives (Delta One listed and OTC products), Electronic Trading (algorithm suite with strategic-partner technology and transparent performance monitoring), and Outsourced Trading (an extension of clients' in-house execution strategy, workflow, technology, analytics, and regulatory compliance). Operates on a fully disclosed, agency-only basis with total anonymity in the marketplace.

2Consulting Services
CategoryFinancial Consulting
Description

Asset-and-security-type-agnostic consultative offerings including Risk Management (liquidity, financing, balance sheet management, synthetic exposure, collateral optimization, regulatory guidance), Portfolio Solutions (portfolio construction, asset analysis, hedging, yield enhancement), Execution Consulting (total-cost-and-risk minimization using quantitative modeling), and Intelligence (bespoke macro-to-micro insights, impact studies, daily commentary).

3Capital Markets
CategoryInvestment Banking & Capital Markets
Description

Investment banking and capital markets services including IPO Services, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, with over $1.5 billion raised in equity and debt capital. Specialty focus on small to medium-sized innovative Biotech, Pharmaceutical, Medtech, Diagnostic, and Telehealth companies, executed as bookrunner, co-bookrunner, sole placement agent, and underwriting roles.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthersAnnounced on2026-05-13
Description

Provided escrow services for SU Group Holdings public offering. Served as escrow agent in connection with registration rights and escrow agreements.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Boutique investment bank and broker-dealer with capital markets and institutional execution offerings. Comparable scale and target client profile, particularly on mid-market equity capital raises.

TypeDirect peer
Description

Boutique broker-dealer providing institutional execution, research, and investment banking services. Comparable in size and institutional client focus.

TypeDirect peer
Description

Boutique full-service broker-dealer and investment bank with institutional execution, capital markets, and advisory offerings. Comparable in size and service mix to WallachBeth across equities execution and mid-market IB.

TypeDirect peer
Description

Boutique institutional broker specializing in equity execution and outsourced trading for asset managers. Directly comparable on the outsourced trading and agency execution proposition.

TypeDirect peer
Description

Boutique agency execution and trade analytics firm serving institutional asset managers and hedge funds. Closest like-for-like peer given similar agency-only positioning, focus on execution quality, and institutional client base.

TypeBroad incumbent
Description

Nomura-owned institutional broker-dealer with global agency execution and electronic trading. Overlaps with WallachBeth on equities execution and electronic trading, though at substantially greater scale.

TypeBroad incumbent
Description

Institutional trading network and execution venue for block equities and fixed income. Larger and more established, but comparable institutional client base and execution-focused product set.

TypeDirect peer
Description

Boutique broker-dealer and investment bank with strong focus on small/mid-cap healthcare and biotech capital markets. Directly comparable on the small-cap healthcare IPO and follow-on offering workflow.

TypeDirect peer
Description

Institutional broker-dealer with agency execution and capital markets capabilities serving hedge funds and asset managers. Comparable scale and structure, with overlapping execution and equity capital markets offerings.

10GTS
TypeBroad incumbent
Description

Electronic market maker and institutional execution provider operating a proprietary ATS. Larger scale and different model (principal), but competes for institutional equities and ETF execution flow.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WallachBeth Capital

Institutional Brokerage & Capital Marketswallachbeth.com

WallachBeth Capital is a privately held, FINRA-registered broker-dealer that provides agency-only institutional execution, consulting, and capital markets services to asset managers, hedge funds, and small-to-mid-cap healthcare/biotech issuers, with over $1.5 billion raised for clients since 2014.

What WallachBeth Capital does

WallachBeth Capital is a privately held, FINRA-registered broker-dealer founded in 2014 and headquartered in Jersey City, NJ with an additional office in Boca Raton, FL. The firm operates on a fully disclosed, agency-only basis across three integrated service lines: Execution Services (custom execution in equities, ETFs, and derivatives, including risk-market liquidity sourcing, creation/redemption baskets, high-touch program trading, NAV markets, and algorithmic venues, plus outsourced trading for asset managers); Consulting Services (risk management, portfolio solutions, execution consulting, and bespoke market intelligence); and Capital Markets (IPOs, registered direct offerings, PIPEs, private placements, bridge financing, and financial advisory, with a stated track record of over $1.5 billion in equity and debt capital raised for clients). The firm does not own an ATS or operate a principal market-making desk, which is the structural source of its "no conflicts" positioning.

The platform's underlying technology stack comprises an internal proprietary electronic trading platform (Phase I rolled out in 2020) and a comprehensive algorithm suite leveraging partner-provided technology, with no disclosed in-house AI/ML capabilities. Revenue is generated via transaction-based execution fees, capital markets placement and underwriting fees, and professional-services consulting fees, with pricing not publicly disclosed and negotiated on a relationship basis. Distribution is direct via sales-led, enterprise-style relationship management rather than through reseller or platform channels.

WallachBeth serves two primary customer segments: (1) institutional investors — asset managers, hedge funds, and financial institutions — that require agency execution, derivatives facilitation, and outsourced trading; and (2) small-to-mid-cap innovative companies in biotech, pharmaceutical, medtech, diagnostic, and telehealth that need capital markets and investment banking expertise. A separate Financial Services and FinTech vertical was established in 2018 under Managing Director Dave Mortimer. The firm also maintains ecosystem marketing through its annual Park City Symposium, financial media appearances on CNBC and Bloomberg, and industry event sponsorships.

WallachBeth Capital firmographics

Firmographics
Name
WallachBeth Capital
Legal name
WallachBeth Capital, LLC
Website
https://wallachbeth.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
WallachBeth Capital is a privately held, FINRA-registered broker-dealer that provides agency-only institutional execution, consulting, and capital markets services to asset managers, hedge funds, and small-to-mid-cap healthcare/biotech issuers, with over $1.5 billion raised for clients since 2014.
Ownership category
akta.pro rank

WallachBeth Capital industry classification

Industry
Product category
Institutional Brokerage & Capital Markets
NAICS
Investment Banking and Securities Intermediation (523150), Investment Banking and Securities Intermediation (52315), Portfolio Management and Investment Advice (52394)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
akta.pro primary industry
Agency Equity Execution (Cash Equities) (FSACAFAA)
akta.pro secondary industries
Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC), Prime Brokerage Financing (Margin/Stock Loan) (FSACAIAD)

Keywords

  • Institutional execution services
  • Agency-only brokerage
  • Capital markets advisory
  • ETF and equity trading
  • Healthcare investment banking

Where WallachBeth Capital is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

WallachBeth Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Capital Markets and Investment Banking Services: Fees earned from capital raising activities including IPOs, registered direct offerings, follow-on offerings, PIPE offerings, private placements, uplisting transactions, bridge financing, and financial advisory for small to medium-sized healthcare and biotech companies. WallachBeth has helped companies raise over $1.5 billion in equity and debt capital.
  2. Institutional Execution Services: Agency-based execution services for equities, ETFs, and derivatives. Operating on fully disclosed, agency-only basis providing execution strategies, consulting, and outsourced trading capabilities to institutional clients.
  3. Consulting Services: Consultative services including risk management, portfolio solutions, execution consulting, and intelligence. Services are asset and security-type agnostic.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

WallachBeth Capital product offering

Product offering

Core offering

WallachBeth Capital is a boutique institutional broker-dealer providing execution, consulting, and capital markets services on a fully disclosed, agency-only basis. Its Execution practice delivers equities, ETF, and derivatives execution with algorithmic and outsourced trading capabilities for asset managers and hedge funds. Its Capital Markets practice provides investment banking services — IPOs, registered direct offerings, PIPE offerings, private placements, uplistings, bridge financing, and financial advisory — focused on small-to-mid-cap healthcare and biotech issuers, with over $1.5 billion in client capital raised.

Product overview

WallachBeth Capital is a leading provider of institutional execution services offering a unified platform of Execution, Consulting, and Capital Markets services. The Execution Services core product includes Equities & ETFs, Derivatives, Electronic Trading, and Outsourced Trading sub-products that help institutions navigate complex markets on an agency-only basis. The Consulting Services encompass Risk Management, Portfolio Solutions, Execution Consulting, and Intelligence offerings. The Capital Markets division provides investment banking services including IPOs, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, having helped companies raise over $1.5 billion in Equity and Debt Capital, with a specialty focus on small to medium-sized innovative Biotech/Pharmaceutical/Medtech/Diagnostic/Telehealth companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Execution Services Institutional execution solutions spanning equities, ETFs, and derivatives, including Equities & ETFs (risk markets, creation/redemption baskets, high-touch program trading, NAV markets, algorithmic venues), Derivatives (Delta One listed and OTC products), Electronic Trading (algorithm suite with strategic-partner technology and transparent performance monitoring), and Outsourced Trading (an extension of clients' in-house execution strategy, workflow, technology, analytics, and regulatory compliance). Operates on a fully disclosed, agency-only basis with total anonymity in the marketplace.
  • Consulting Services Asset-and-security-type-agnostic consultative offerings including Risk Management (liquidity, financing, balance sheet management, synthetic exposure, collateral optimization, regulatory guidance), Portfolio Solutions (portfolio construction, asset analysis, hedging, yield enhancement), Execution Consulting (total-cost-and-risk minimization using quantitative modeling), and Intelligence (bespoke macro-to-micro insights, impact studies, daily commentary).
  • Capital Markets Investment banking and capital markets services including IPO Services, Registered Direct Offerings, PIPE Offerings, Private Placements, Bridge Financing, and Financial Advisory, with over $1.5 billion raised in equity and debt capital. Specialty focus on small to medium-sized innovative Biotech, Pharmaceutical, Medtech, Diagnostic, and Telehealth companies, executed as bookrunner, co-bookrunner, sole placement agent, and underwriting roles.

Quantifiable outcome

  • Over $1.5 billion in equity and debt capital raised for client companies

Companies that use WallachBeth Capital

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

WallachBeth Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

WallachBeth Capital partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Continental Stock Transfer & Trust CompanyminorOthers · 13 May 2026Provided escrow services for SU Group Holdings public offering. Served as escrow agent in connection with registration rights and escrow agreements.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

WallachBeth Capital competitors and assessment

Company assessment

Direct peers

  • EF Hutton: Boutique investment bank and broker-dealer with capital markets and institutional execution offerings. Comparable scale and target client profile, particularly on mid-market equity capital raises.
  • Aegis Capital: Boutique broker-dealer providing institutional execution, research, and investment banking services. Comparable in size and institutional client focus.
  • Loop Capital Markets: Boutique full-service broker-dealer and investment bank with institutional execution, capital markets, and advisory offerings. Comparable in size and service mix to WallachBeth across equities execution and mid-market IB.
  • AtonRā: Boutique institutional broker specializing in equity execution and outsourced trading for asset managers. Directly comparable on the outsourced trading and agency execution proposition.
  • Abel Noser Holdings: Boutique agency execution and trade analytics firm serving institutional asset managers and hedge funds. Closest like-for-like peer given similar agency-only positioning, focus on execution quality, and institutional client base.
  • Maxim Group: Boutique broker-dealer and investment bank with strong focus on small/mid-cap healthcare and biotech capital markets. Directly comparable on the small-cap healthcare IPO and follow-on offering workflow.
  • Rosenblatt Securities: Institutional broker-dealer with agency execution and capital markets capabilities serving hedge funds and asset managers. Comparable scale and structure, with overlapping execution and equity capital markets offerings.

Broad incumbents

  • Instinet: Nomura-owned institutional broker-dealer with global agency execution and electronic trading. Overlaps with WallachBeth on equities execution and electronic trading, though at substantially greater scale.
  • Liquidnet: Institutional trading network and execution venue for block equities and fixed income. Larger and more established, but comparable institutional client base and execution-focused product set.
  • GTS: Electronic market maker and institutional execution provider operating a proprietary ATS. Larger scale and different model (principal), but competes for institutional equities and ETF execution flow.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

WallachBeth Capital social profiles

Digital presence

WallachBeth Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WallachBeth Capital leadership team

Management profile

Number of profiles

Profiles10 records

WallachBeth Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WallachBeth Capital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WallachBeth Capital

What does WallachBeth Capital do?

WallachBeth Capital is a boutique institutional broker-dealer providing execution, consulting, and capital markets services on a fully disclosed, agency-only basis. Its Execution practice delivers equities, ETF, and derivatives execution with algorithmic and outsourced trading capabilities for asset managers and hedge funds. Its Capital Markets practice provides investment banking services — IPOs, registered direct offerings, PIPE offerings, private placements, uplistings, bridge financing, and financial advisory — focused on small-to-mid-cap healthcare and biotech issuers, with over $1.5 billion in client capital raised.

Is WallachBeth Capital a public or private company?

WallachBeth Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was WallachBeth Capital founded?

WallachBeth Capital was founded in 2014. It employs 51 to 100 people.

Where is WallachBeth Capital based?

WallachBeth Capital is headquartered in New York, United States, in the North America region.

How does WallachBeth Capital make money?

Three revenue lines are on record. Capital Markets and Investment Banking Services are the primary driver. The others are institutional Execution Services and consulting Services.

Who are WallachBeth Capital's main competitors?

Direct peers on record are EF Hutton, Aegis Capital, Loop Capital Markets, AtonRā, Abel Noser Holdings, Maxim Group and Rosenblatt Securities. Broad incumbents are Instinet, Liquidnet and GTS.

Does WallachBeth Capital have an API?

No public API is recorded for WallachBeth Capital.

What industry is WallachBeth Capital in?

WallachBeth Capital's product category is Institutional Brokerage & Capital Markets. Its primary akta.pro industry code is FSACAFAA, Agency Equity Execution (Cash Equities), with a secondary code of FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked). Its NAICS code is 523150 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooWallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesbioAffinity Technologies closed a $4 million registered direct financing of common stock and a concurrent private placement of warrants at $6.122 per share. The company will use net proceeds for working capital and to support sales of its CyPath Lung test for lung cancer.PR NewswireWallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesbioAffinity Technologies closed a registered direct offering of common stock and a concurrent private placement of warrants, priced at $6.122 per share. The offering raised approximately $4 million in gross proceeds, which the company will use for working capital and to support sales of its CyPath Lung test.PR NewswireWallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesbioAffinity Technologies agreed to sell common stock and pre-funded warrants at $6.122 per share in a registered direct offering, with concurrent private placement warrants. Gross proceeds are expected to be approximately $4 million, to be used for working capital and supporting sales of its CyPath Lung test.TradingViewTenon Medical Raises $2.87M Via Warrant Exercise, Issues 858K New Warrants; Engages WallachBethTenon Medical executed a warrant exercise inducement generating $2.87 million in gross proceeds from an existing holder exercising Series A warrants at $5.02 per share. The company issued 858,269 unregistered Series B warrants at the same price, exercisable for five years, and engaged WallachBeth Capital as financial advisor for a 7% fee.GurufocusWallachBeth Capital Announces Closing of Tenon Medical Warrant ITenon Medical closed a warrant inducement offering with an institutional investor, receiving $2,872,338.58 in gross cash proceeds. The investor exercised 572,179 existing warrants and received new warrants to buy up to 858,269 shares at $5.02 per share. The new warrants are immediately exercisable and expire five years from issuance.YahooWallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338Tenon Medical closed a warrant inducement with an institutional investor, receiving $2,872,338.58 for 572,179 existing warrants. The investor received new warrants to buy 858,269 shares at $5.02 each, exercisable for five years. WallachBeth Capital acted as financial advisor.MorningstarWallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338Tenon Medical closed a warrant inducement offering with an institutional investor, receiving gross proceeds of $2,872,338.58 for 572,179 existing warrants. The investor received new warrants to buy up to 858,269 shares at $5.02 per share, exercisable for five years. WallachBeth Capital acted as financial advisor.GurufocusWallachBeth Capital Announces Tenon Medical Warrant Inducement fTenon Medical entered into warrant exercise agreements with an institutional investor to exercise 572,179 existing warrants for gross proceeds of $2,872,338.58. The investor will receive new warrants to purchase up to 858,269 shares at $5.02 per share, with closing expected on September 14, 2026.PR NewswireWallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338Tenon Medical entered into warrant exercise agreements with an institutional investor to exercise 572,179 existing warrants for gross proceeds of $2,872,338.58. The holder will receive new warrants to purchase up to 858,269 shares at $5.02 per share, with closing expected on September 14, 2026.Gurufocus/C O R R E C T I O N -- WallachBeth Capital LLC/Tenon Medical closed a private placement with an institutional investor, selling 597,610 shares and warrants for an estimated $3 million. The combined effective offering price was $5.02 per share, with warrants exercisable at $5.02 and pre-funded warrants at $0.001. The company will use proceeds for its medical device business.